Debets-Ossenkopp Y J, Pot R G, van Westerloo D J, Goodwin A, Vandenbroucke-Grauls C M, Berg D E, Hoffman P S, Kusters J G
Department of Medical Microbiology, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands.
Antimicrob Agents Chemother. 1999 Nov;43(11):2657-62. doi: 10.1128/AAC.43.11.2657.
We found that NCTC11637, the type strain of Helicobacter pylori, the causative agent of peptic ulcer disease and an early risk factor for gastric cancer, is metronidazole resistant. DNA transformation, PCR-based restriction analysis, and DNA sequencing collectively showed that the metronidazole resistance of this strain was due to mutation in rdxA (gene HP0954 in the full genome sequence of H. pylori 26695) and that resistance did not depend on mutation in any of the other genes that had previously been suggested: catalase (katA), ferredoxin (fdx), flavodoxin (fldA), pyruvate:flavodoxin oxidoreductase (porgammadeltaalphabeta), RecA (recA), or superoxide dismutase (sodB). This is in accord with another recent study that attributed metronidazole resistance to point mutations in rdxA. However, the mechanism of rdxA inactivation that we found in NCTC11637 is itself also novel: insertion of mini-IS605, one of the endogenous transposable elements of H. pylori, and deletion of adjacent DNA sequences including 462 bp of the 851-bp-long rdxA gene.
我们发现,幽门螺杆菌的模式菌株NCTC11637对甲硝唑耐药,幽门螺杆菌是消化性溃疡疾病的病原体及胃癌的早期危险因素。DNA转化、基于PCR的限制性分析和DNA测序共同表明,该菌株对甲硝唑耐药是由于rdxA(幽门螺杆菌26695全基因组序列中的HP0954基因)发生突变,且耐药性不依赖于之前提出的任何其他基因的突变:过氧化氢酶(katA)、铁氧化还原蛋白(fdx)、黄素氧化还原蛋白(fldA)、丙酮酸:黄素氧化还原蛋白氧化还原酶(porgammadeltaalphabeta)、RecA(recA)或超氧化物歧化酶(sodB)。这与最近另一项将甲硝唑耐药归因于rdxA点突变的研究一致。然而,我们在NCTC11637中发现的rdxA失活机制本身也是新颖的:mini-IS605(幽门螺杆菌的内源性转座元件之一)插入,以及包括851 bp长的rdxA基因中462 bp的相邻DNA序列缺失。